A facile, inexpensive scalable route to α-methyl cysteine by Johnston, Heather J & Hulme, Alison N
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A facile, inexpensive scalable route to -methyl cysteine
Citation for published version:
Johnston, HJ & Hulme, AN 2013, 'A facile, inexpensive scalable route to -methyl cysteine' Synlett, vol 24,
no. 5, ST-2013-D0069-L, pp. 591-594. DOI: 10.1055/s-0032-1318316
Digital Object Identifier (DOI):
10.1055/s-0032-1318316
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Peer reviewed version
Published In:
Synlett
Publisher Rights Statement:
Copyright © 2013 Georg Thieme Verlag Stuttgart & New York. All rights reserved.
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 28. Apr. 2017
 A Facile, Inexpensive and Scalable Route to Thiol Protected 
-Methyl Cysteine** 
Heather J. Johnston and Alison N. Hulme* 
 
[1]
EaStCHEM,
 
School of Chemistry, Joseph Black Building, University of Edinburgh, West Mains 
Road, Edinburgh, EH9 3JJ, UK. 
[
*
]
Corresponding author; e-mail: Alison.Hulme@ed.ac.uk, tel.: + 44 131 650 4711, 
fax: + 44 131 650 4743
 
[
**
]
We thank the EPSRC (DTA) and Cancer Research UK for funding. 
Supporting information: 
Supporting information including the preparation of -methyl cysteine 10, and 
1
H and 
13
C spectra for all 
compounds is available online at http://www.thieme-connect.com/ejournals/toc/synlett 
 
Graphical abstract: 
 
Keywords: 
natural products, -methyl cysteine, solid phase peptide synthesis, camphor sultam auxiliary, P2-Et. 
  
This document is the Accepted Version of a published article that appeared in final form 
in Synlett, copyright © Georg Thieme Verlag Stuttgart · New York. To access the final 
edited and published work see http://dx.doi.org/10.1055/s-0032-1318316 
 
Cite as: 
Johnston, H. J., & Hulme, A. N. (2013). A facile, inexpensive scalable route to α-methyl 
cysteine. Synlett, 24(5), 591-594. 
 
Manuscript received: 22/01/2013; Accepted: 06/02/2013; Article published: 25/02/2013 
Page 1 of 9 
Abstract 
A facile, scalable synthesis of -methyl cysteine with three alternate thiol protecting groups (Trt, 
Allyl and 
t
Bu) is described. The thiol protected amino acids are obtained in 6 steps from L-cysteine 
ethyl ester and are ideally suited for a range of natural product and solid phase peptide synthesis 
applications. 
 
Introduction 
Both the (R)- and (S)-enantiomers of -methyl cysteine occur in Nature and they are often found 
incorporated within a thiazoline ring.1 Many -methyl cysteine containing natural products exhibit 
interesting pharmaceutical properties, e.g. bisebromoamide 1 (Figure 1) has anticancer activity at 
nanomolar levels against a wide range of cancer lines;2 thiangazole 2 has anti-HIV activity and is 
highly selective for HIV-1 over HIV-2;3 desferrithiocin 3 is an iron chelator with antineoplastic 
activity4 and didehydromirabazole A 4 is an anticancer agent which exhibits selectivity for solid 
tumours.5 -Methyl cysteine is also frequently used in the field of peptide mimetics where 
quaternization of the -centre: (i) prevents racemization, which otherwise is comparatively facile 
under both acidic and basic conditions;6 (ii) restricts rotation about the N-Cand C-
C(O)bonds, which can stabilize a preferred peptide conformation;7 and (iii) enhances stability 
towards enzymatic degradation, thus increasing biological half-life.8


Figure 1. -Methyl cysteine containing natural products. 
Page 2 of 9 
A comprehensive review of approaches to the asymmetric synthesis of -methyl cysteine was 
published by Singh in 2004 and identifies five common strategies: thiolation of a bromomethyl 
bislactam ether; regioselective ring opening of a chiral aziridine or -lactone; utilization of Seebach’s 
“self-regeneration of chirality” approach; enzymatic resolution; and use of a camphorsultam chiral 
auxiliary to direct methylation of a thiazoline.6 Alternate routes have since been published, but these 
often require either expensive, non-commercial phase transfer catalysts,9 utilize time-consuming 
enzymatic resolution,7,10 or employ microwave technologies.8 Our goal was to optimize a reliable, 
inexpensive, scalable route to optically pure -methyl cysteine for solid phase peptide synthesis 
(SPPS), peptoid mimetic and natural product synthesis applications. Three thiol protecting groups [S-
trityl (Trt), S-allyl (Allyl) and S-tert-butyl (tBu)] were targeted to provide appropriate oxidation-
resistant, bench-stabile thiol-protected derivatives. 
Whilst the asymmetric allylation, or benzylation, of appropriately functionalized thiazolines may be 
achieved using both cinchona and tertiary ammonium salt based PTCs;9 the yields and % ee’s 
obtained for aliphatic alkylation are generally poor. Thus in selecting a scalable synthetic route to -
methyl cysteine we were attracted to the precedented use of camphorsultam to direct the alkylation of 
thiazolines; not least due to the excellent handling properties which this auxiliary conveys (including 
the generation of crystalline intermediates, and its ease of removal and recycling) which we believed 
would outweigh the disadvantages of an auxiliary-based approach when working on a gram scale.11 
The required thiazoline precursor 6 (Scheme 1), was readily formed by reacting (R)-cysteine ethyl 
ester hydrochloride 5 and ethyl benzimidate hydrochloride in the presence of a tertiary amine base. 
Subsequent coupling to (1S)-()-2,10-camphorsultam 7 was achieved using AlMe3; but while the 
reaction itself was not particularly problematic, purification proved troublesome. The desired product 
8a is described in the literature as colourless and crystalline,11 however purification by column 
chromatography using a range of solvent systems rarely provided pure product and recrystallization 
also proved unsuccessful. The optimized purification method developed involved gentle heating of the 
crude product in diethyl ether followed by filtration.12 Using this method, a colourless crystalline 
product 8a was obtained in good yield (as an ~1:1 epimeric mixture in the thiazoline ring) which 
could be used directly in the subsequent step. 
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Scheme 1. Synthesis of -methyl cysteine. Reagents and Conditions: (a) PhC(=NH)OEt•HCl, MeOH, 
Et3N, rt, 24 h (95%); (b) (1S)-()-2,10-camphorsultam 7, Me3Al, PhCH3, 55 °C, 24 h (76%); (c) P2-
Et, MeI, TBAB, CH2Cl2, -78 °C, 1 h (99%); (d) LiOH (1 M aq), THF, rt, 30 min; (e) HCl (6 M aq), 
reflux, 24 h (89% over 2 steps). 

Removal of the enolisable H in 8a gives a planar intermediate,11 the faces of which may be readily 
discriminated in the presence of the bulky camphorsultam, allowing for highly diastereoselective 
methylation. Pennington et al. have used BuLi in the presence of HMPA to effect this 
transformation,11 but the yields obtained were modest and the use of HMPA on scale is not desirable.13 
In contrast, phosphazene bases provide an attractive alternative as extremely strong, non-ionic, non-
charged nitrogen bases which generate highly reactive “naked” enolates.14 Phosphazene bases also 
exhibit very low nucleophilicity and hence are comparatively inert towards the electrophilic 
component of a reaction. We opted to use the phosphazene base P2-Et,15 as methylation of the 
oxazoline 8b has been reported to proceed in high yield with excellent diastereoselectivity in the 
presence of this base.15 The reaction of 8a was found to proceed in high yield with 1 equivalent of P2-
Et in 1 hour in the presence of the phase transfer catalyst TBAB. Attempts to reduce the loading of 
P2-Et to sub-stoichiometric levels (e.g. 10 mol%) were unsuccessful, resulting in sluggish reaction 
times and poor yields of product (~50%). The product was purified by column chromatography to 
give a colourless solid, methylated thiazoline 9, as a single diastereomer. While the mass 
spectrometric and []D values of this compound matched those of the literature, there was a 
significant shift in the  value which we observed in the 1H NMR for the CH3 of the newly-introduced 
methyl group (1.69 vs  2.5011). However, comparison of our NMR data to that of the oxazoline 
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reported by S. Jew et al.,15 and other similar thiazolines1,16 gave us full confidence in the outcome of 
this methylation reaction. 
A two-step procedure for the removal of the auxiliary and hydrolysis of the thiazoline ring was found 
to provide optimum yields. The auxiliary was efficiently removed with LiOH (1 M aq); the (1S)-()-
2,10-camphorsultam 7 was recovered in 89% yield and could be recycled following recrystallization 
from ethanol. The thiazoline ring was then cleaved using HCl (6 M aq) to liberate -methyl cysteine. 
Purification of the -methyl cysteine from the benzoic acid by-product was attempted using DOWEX 
50WX8-200 resin with an initial eluant of pH 3 citrate buffer followed by 5% ammonium hydroxide 
solution to liberate the amino acid. Whilst removal of the by-product was successful, NMR analysis 
indicated the presence of citric acid (which acts as a stabilizer for the reduced cysteine). Any attempts 
to further purify 10 using this process resulted in dimerization to the corresponding cystine; a process 
which could be readily followed by NMR (cysteine CH2  CHAHB CHAHB  vs cystine 
CH2  CHAHB CHAHB ). Fortunately, an alternative strategy employing azeotropic 
removal of residual water from the crude product mixture using toluene17 caused the hydrochloride 
salt of -methyl cysteine 10 to precipitate allowing its facile separation from the reaction by-product. 
Using this method, the hydrochloride salt 10 was isolated in excellent yield (89% over 2 steps). 
To provide derivatives of -methyl cysteine with extended bench-stability, three different sulfur 
protecting groups were targeted: the S-trityl (Trt), S-allyl (Allyl) and S-tert-butyl (tBu) groups (11a-c, 
Scheme 2). Whilst all three protecting groups are widely employed in SPPS strategies only the Trt and 
tBu protected derivatives of (R)-10 have previously been reported. 
 
 
Scheme 2. Thiol-protection of -methyl cysteine. Reagents and Conditions: (a) H3PO4 (85% aq), Ph-
3COH, PhCH3, reflux, 1 h (92%); (b) H2C=CHCH2Br, NH4OH (2 M aq), rt, 18 h (78%); (c) 
tBuOH, 
HCl (37 % aq), 50 °C, 18 h (81%). 
 
Trityl protection was achieved using a method developed by M. Yus et al.18 Phosphoric acid (85 %, 
aq) was added to a solution of 10 and triphenyl methanol in toluene. Reflux for 1 hour gave the salt of 
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11a in high yield as a colourless crystalline solid. Introduction of the allyl group to give 11b was 
achieved using allyl bromide and NH4OH (2 M aq) following a procedure reported by Y. Tsantrizos et 
al.19 Finally, the tert-butyl group was introduced following a slightly modified version of the 
procedure described by Chimiak et al.;20 thus 10 was dissolved in HCl (37 % aq) and heated at 50 °C 
in the presence of tert-butyl alcohol to produce 11c.  
In conclusion, we report a simple, inexpensive, scalable and repeatable synthesis of -methyl cysteine 
(5 steps from commercial cysteine ethyl ester hydrochloride, 64% overall yield). This route can be 
easily adapted to incorporate alternate sulfur protecting groups, which has been illustrated by the 
synthesis of three different species. It is anticipated that these products will find application in SPPS 
as their Fmoc derivatives, incorporation into the synthesis of a range of natural products and, in the 
case of 11b, might provide an elimination-resistant modified cysteine with potential for RCM peptide 
stapling,21,22 and bioorthogonal protein modification23 through cross-metathesis24 and the thiol-ene 
click (TEC) reaction.25 
 
Experimental section 
(2R)-2-Amino-2-methyl-3-[(triphenylmethyl)-sulfanyl]propanoic acid phosphate salt11: 
Phosphoric acid (0.2 mL; 85 % aq) was added to a stirred solution of -methyl cysteine hydrochloride 
10 (100 mg, 0.58 mmol) and trityl alcohol (0.15 g, 0.58 mmol) in toluene (5 mL) at rt. The reaction 
mixture was heated at reflux for 1 h, cooled to rt and then the reaction mixture was concentrated in 
vacuo. Water (5 mL) was added and the crude product was stirred for a further 30 min, then filtered 
and recrystallized from methanol to give the desired product 11a as a colourless solid (202 mg, 92 %). 
Rf (MeOH:DCM, 1:9) = 0.21; []D = +30.0 (c 1.00, MeOH); mp 178-180 °C, lit.
11 mp 179-180 ºC; 
IR (neat, cm-1) 3471 (N–H), 3600–2580 (O–H), 1730 (C=O), 1630 (Ar), 1593 (Ar), 1512 (Ar); 1H 
NMR δ (500 MHz, DMSO) 7.38–7.24 (15H, m, ArH), 3.50 (2H, br s, NH2), 2.45 (1H, d, J = 11.7 Hz, 
CHACHB), 2.39 (1H, d, J = 11.7 Hz, CHACHB), 1.22 (3H, s, CCH3); 
13C NMR δ (126 MHz, DMSO) 
171.12 (C), 143.96 (3 × C), 129.08 (6 × CH), 128.11 (6 × CH), 126.88 (3 × CH), 65.99 (C), 58.67 
(CH2), 21.96 (CH3), trityl C absent; m/z (ESI+, MeOH) 378 ([M+H]
+, 24%), 243 (100), 179 (10). 1H 
and 13C spectroscopic data in good agreement with literature.11 
(2R)-2-Amino-2-methyl-3-[(prop-2-en-1-yl)sulfanyl]-propanoic acid26: Allyl bromide (0.08 mL, 
0.87 mmol) was added to a stirred solution of -methyl cysteine hydrochloride 10 (100 mg, 0.58 
mmol) in NH4OH (2 mL, 2 M aq) at rt. The reaction mixture was stirred at rt for 18 h then the product 
was concentrated in vacuo. The crude product was then recrystallized from EtOH to give the desired 
product 11b as a colourless solid (79.6 mg, 78%). Rf (MeOH:DCM, 1:9) = 0.45; []D = 25.0 (c 0.40, 
H2O); mp 257-259 °C, lit.
23 mp 260 ºC; IR (neat, cm-1) 3454 (N–H), 3419 (N–H), 3230–2700 (O–H), 
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1738 (C=O), 1605 (C=C), 1597 (COO-); 1H NMR δ (400 MHz, D2O) 5.83–5.69 (1H, m, CH=CH2), 
5.20–5.08 (2H, m, CH=CH2), 3.22–3.08 (2H, m, CH2), 3.05 (1H, d, J = 14.5 Hz, CHACHB), 2.71 (1H, 
d, J = 14.5 Hz, CHACHB), 1.45 (3H, s, CCH3).; 
13C NMR δ (126 MHz, D2O) 175.30 (C), 133.72 
(CH), 118.33 (CH2), 61.14 (C), 36.85 (CH2), 34.94 (CH2), 22.20 (CH3); m/z (ESI+, MeOH/DCM) 176 
([M+H]+, 29%), 159 (25), 144 (24), 136 (30), 114 (27), 110 (40). IR data in good agreement with 
literature.26 
(2R)-2-Amino-3-(tert-butylsulfanyl)-2-methyl-propanoic acid hydrochloride salt17b: Hydrochloric 
acid (2.5 mL; 37 % aq) was added to a stirred solution of -methyl cysteine hydrochloride 10 (100 
mg, 0.58 mmol) in tert-butanol (0.56 g, 5.8 mmol) at rt. The reaction mixture was heated to 50 °C and 
stirred for ~18 h at the same temperature. Once the reaction was judged to be complete, the reaction 
mixture was concentrated in vacuo until most of the solvent had been removed. On standing overnight 
at rt colourless crystals formed. The crystals were collected by filtration to give the desired product 
11c as a colourless solid (90.3 mg, 81%). Rf (MeOH:DCM, 1:9) = 0.10; []D = .0 (c 0.40, H2O); 
mp 272-274 °C, lit.17b mp 272-275 ºC; IR (neat, cm-1) 3389 (N–H), 3333 (N–H), 3100–2750 (O–H), 
1734 (C=O); 1H NMR δ (500 MHz, D2O) 3.13 (1H, d, J = 13.4 Hz, CHAHBS), 2.93 (1H, d, J = 13.4 
Hz, CHAHBS), 1.56 (3H, s, CCH3), 1.26 (9H, s, C(CH3)3); 
13C NMR δ (126 MHz, D2O) 173.31 (C), 
60.07 (C), 43.51 (C), 34.09 (CH2), 29.74 (3 × CH3), 21.79 (CH3); (ESI+, MeOH/DCM) 192 ([M+H]
+, 
58%), 137 (72), 136 (100), 119 (88), 101 (81), 90 (72). 1H and 13C spectroscopic data in good 
agreement with literature.17b 
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